Insulin syringe unit conversion: difference between revisions
Diff·revision 35 → 36·00:30, 18 Jun 2025
Difference between revision 35 and revision 36 of Insulin syringe unit conversion. 4 lines changed; the page grew by 635 bytes.
| Revision 35 — 21:45, 6 Jun 2025 DisclosureDido (talk) fix hyphenation per PP:MOS 4,444 bytes ±0 | Revision 36 — 00:30, 18 Jun 2025 ArchiveBot (talk) bot: sort category members 5,079 bytes +635 | ||
|---|---|---|---|
| 52 | | 20 mg/mL | 200 µg | 1.0 mg | 2.0 mg | 4.0 mg | 8.0 mg | | 52 | | 20 mg/mL | 200 µg | 1.0 mg | 2.0 mg | 4.0 mg | 8.0 mg | |
| 53 | 53 | ||
| + | 54 | Two observations follow. A tenfold error in assumed concentration produces a tenfold error in delivered mass with no change in the syringe reading and nothing visibly wrong. And at high concentrations a single graduation carries a large mass, so the resolution of the syringe becomes the limiting factor on dose precision: at 20 mg/mL, one unit is 200 µg, and half a graduation cannot be read reliably.{{r|iso7886b}} | |
| + | 55 | ||
| 54 | == References == | 56 | == References == |
| 55 | {{reflist}} | 57 | {{reflist}} |
| 56 | <ref name="iso8537">ISO 8537, ''Sterile single-use syringes, with or without needle, for insulin''. International Organization for Standardization.</ref> | 58 | <ref name="iso8537">ISO 8537, ''Sterile single-use syringes, with or without needle, for insulin''. International Organization for Standardization.</ref> |
| + | 59 | <ref name="iso7886b">ISO 7886-1, ''Sterile hypodermic syringes for single use — Part 1: Syringes for manual use''. International Organization for Standardization.</ref> | |
| 57 | <ref name="fdavet">US Food and Drug Administration, Center for Veterinary Medicine — guidance on U-40 insulin products and syringe compatibility.</ref> | 60 | <ref name="fdavet">US Food and Drug Administration, Center for Veterinary Medicine — guidance on U-40 insulin products and syringe compatibility.</ref> |
| 58 | 61 | ||
| ⋮ | ⋮ | ||
| 62 | * [[Syringe dead space]] | 65 | * [[Syringe dead space]] |
| 63 | * [[Subcutaneous injection]] | 66 | * [[Subcutaneous injection]] |
| + | 67 | * [[Reconstitution of lyophilised peptides]] | |
| 64 | 68 | ||
| 65 | {{DEFAULTSORT:Insulin syringe unit conversion}} | 69 | {{DEFAULTSORT:Insulin syringe unit conversion}} |